Jiangsu Gdk Biological Technology Co., Ltd (JIANGSU GDK BIOTECHNOLOGY CO LT) aksje
688670.SS
¥15.48-0.34 (-2.15%)
Laster graf...
JIANGSU GDK BIOTECHNOLOGY CO LT
Market Cap
$1,907,136,000
Åpning15.70
Høy16.18
Lav15.37
Volum1.03M
P/EN/A
Markedsverdi1.91B
52-ukers høy31.20
52-ukers lav12.52
Gj.sn. volum1.82M
UtbytteN/A
Beta0.27
EPS-1.49
Om Jiangsu Gdk Biological Technology Co., Ltd (JIANGSU GDK BIOTECHNOLOGY CO LT) aksje
Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines. The company offers quadrivalent influenza virus split vaccines. Its human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, herpes zoster, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.
Selskapsinformasjon
Børs: Shanghai (SHH)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
No. 12 Yujin Road
225300 Taizhou, China
225300 Taizhou, China
Telefon: + 86 523 8620 5860
Nettside: https://www.gdkbio.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål